drugset / Trial / NCT02926976
The Optimal Treatment for Treatment-resistant Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The Optimal Treatment for Treatment-resistant Schizophrenia
Timeline
- Start
- 2016-11
- Primary completion
- 2019-09
- Completion
- 2019-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | 15 mg | — |
| Comparator | Aripiprazole | Other / unclassified | 30 mg | — |
| Comparator | Clozapine | Other / unclassified | 300 mg | — |
| Comparator | Clozapine | Other / unclassified | 600 mg | — |
| Comparator | Risperidone | Other / unclassified | 3 mg | — |
| Comparator | Risperidone | Other / unclassified | 6 mg | — |
| Comparator | Valproate | Small molecule | 600 mg | — |
| Comparator | Valproate | Small molecule | 1200 mg | — |